Other compounds producing the ampakine activity profile such as IDRA-21 and Eli Lilly's LY-503,430 along with Unifiram and Sunifiram have been developed by other pharmaceutical companies, but these are only used in animal research at present, and Cortex is the only company currently developing selective ampakine drugs for human use, in partnership with the larger pharmaceutical company Schering-Plough.